Ra Capital Management as of Dec. 31, 2016
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 26 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 27.1 | $185M | 7.1M | 26.15 | |
| Ascendis Pharma A S (ASND) | 16.0 | $110M | 5.4M | 20.24 | |
| Avexis | 13.2 | $90M | 1.9M | 47.73 | |
| Achillion Pharmaceuticals | 8.2 | $56M | 14M | 4.13 | |
| Aquinox Pharmaceuticals | 5.3 | $36M | 2.2M | 16.51 | |
| Zogenix | 4.3 | $30M | 2.5M | 12.15 | |
| Ardelyx (ARDX) | 4.0 | $28M | 1.9M | 14.20 | |
| Foamix Pharmaceuticals | 3.0 | $20M | 1.8M | 11.10 | |
| BioCryst Pharmaceuticals (BCRX) | 2.8 | $19M | 3.0M | 6.33 | |
| Ra Pharmaceuticals | 2.6 | $18M | 1.2M | 15.19 | |
| Protagonist Therapeutics (PTGX) | 2.1 | $15M | 693k | 21.13 | |
| Aimmune Therapeutics | 2.0 | $14M | 678k | 20.45 | |
| Audentes Therapeutics | 1.4 | $9.7M | 532k | 18.27 | |
| Beigene (BGNE) | 1.1 | $7.3M | 240k | 30.36 | |
| Dicerna Pharmaceuticals | 1.0 | $7.0M | 2.4M | 2.88 | |
| Abeona Therapeutics | 0.8 | $5.5M | 1.1M | 4.85 | |
| Strongbridge Bioph shs usd | 0.8 | $5.5M | 2.3M | 2.40 | |
| Tg Therapeutics (TGTX) | 0.7 | $4.7M | 1.0M | 4.65 | |
| Tenax Therapeutics | 0.7 | $4.7M | 2.4M | 1.95 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $4.2M | 591k | 7.07 | |
| Eiger Biopharmaceuticals | 0.6 | $4.1M | 354k | 11.65 | |
| Dimension Therapeutics | 0.6 | $4.0M | 928k | 4.35 | |
| Idera Pharmaceuticals | 0.5 | $3.4M | 2.3M | 1.50 | |
| Medicines Company | 0.4 | $2.7M | 80k | 33.94 | |
| Arca Biopharma | 0.1 | $662k | 232k | 2.85 | |
| Akari Therapeutics | 0.1 | $714k | 101k | 7.04 |
